Table of Contents
International Journal of Proteomics
Volume 2012 (2012), Article ID 397103, 8 pages
http://dx.doi.org/10.1155/2012/397103
Research Article

Plasma Fractionation Enriches Post-Myocardial Infarction Samples Prior to Proteomics Analysis

1San Antonio Cardiovascular Proteomics Center, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78245, USA
2Division of Geriatrics, Gerontology & Palliative Medicine, Department of Medicine, UTHSCSA, San Antonio, TX 78245, USA
3Department of Biochemistry, UTHSCSA, San Antonio, TX 78245, USA

Received 15 March 2012; Accepted 9 April 2012

Academic Editor: William C. S. Cho

Copyright © 2012 Lisandra E. de Castro Brás et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. L. Roger, A. S. Go, D. M. Lloyd-Jones, E. J. Benjamin, and J. D. Berry, “Heart disease and stroke statistics—2012 update: a report from the American Heart Association,” Circulation, vol. 125, pp. e2–e220, 2012. View at Google Scholar
  2. A. T. Yan, R. T. Yan, F. G. Spinale et al., “Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure,” Journal of Cardiac Failure, vol. 12, no. 7, pp. 514–519, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Kelly, G. Cockerill, L. L. Ng et al., “Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study,” European Heart Journal, vol. 28, no. 6, pp. 711–718, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. M. L. Lindsey, J. Gannon, M. Aikawa et al., “Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction,” Circulation, vol. 105, no. 6, pp. 753–758, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Ducharme, S. Frantz, M. Aikawa et al., “Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction,” Journal of Clinical Investigation, vol. 106, no. 1, pp. 55–62, 2000. View at Google Scholar · View at Scopus
  6. N. L. Anderson, M. Polanski, R. Pieper et al., “The human plasma proteome,” Molecular and Cellular Proteomics, vol. 3, no. 4, pp. 311–326, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Karpinski, R. Płaksej, R. Derzhko, A. Orda, and M. Witkowska, “Serum levels of interleukin-6, interleukin-10 and C-reactive protein in patients with myocardial infarction treated with primary angioplasty during a 6-month follow-up,” Polskie Archiwum Medycyny Wewnetrznej, vol. 119, no. 3, pp. 115–121, 2009. View at Google Scholar · View at Scopus
  8. N. D. Brunetti, D. Quagliara, and M. Di Biase, “Troponin ratio and risk stratification in subjects with acute coronary syndrome undergoing percutaneous coronary intervention,” European Journal of Internal Medicine, vol. 19, no. 6, pp. 435–442, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Szulik, J. Stabryla-Deska, J. Boidol, R. Lenarczyk, and Z. Kalarus, “Echocardiography-based qualification and response assessment to cardiac resynchronisation therapy in patients with chronic heart failure. The matrix metalloproteinase-9 substudy,” Kardiologia Polska, vol. 69, pp. 1043–1051, 2011. View at Google Scholar
  10. K. Sakata, K. Iida, N. Mochiduki, and Y. Nakaya, “Brain natriuretic peptide (BNP) level is closely related to the extent of left ventricular sympathetic overactivity in chronic ischemic heart failure,” Internal Medicine, vol. 48, no. 6, pp. 393–400, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. P. A. McCullough, A. Olobatoke, and T. E. Vanhecke, “Galectin-3: a novel blood test for the evaluation and management of patients with heart failure,” Reviews in Cardiovascular Medicine, vol. 12, pp. 200–210, 2011. View at Google Scholar
  12. P. G. Righetti, A. Castagna, F. Antonucci et al., “Proteome analysis in the clinical chemistry laboratory: myth or reality?” Clinica Chimica Acta, vol. 357, no. 2, pp. 123–139, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Nissum, S. Kuhfuss, M. Hauptmann et al., “Two-dimensional separation of human plasma proteins using iterative free-flow electrophoresis,” Proteomics, vol. 7, no. 23, pp. 4218–4227, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Travis, J. Bowen, and D. Tewksbury, “Isolation of albumin from whole human plasma and fractionation of albumin depleted plasma,” Biochemical Journal, vol. 157, no. 2, pp. 301–306, 1976. View at Google Scholar · View at Scopus
  15. A. K. Sato, D. J. Sexton, L. A. Morganelli et al., “Development of mammalian serum albumin affinity purification media by peptide phage display,” Biotechnology Progress, vol. 18, no. 2, pp. 182–192, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. D. L. Rothemund, V. L. Locke, A. Liew, T. M. Thomas, V. Wasinger, and D. B. Rylatt, “Depletion of the highly abundant protein albumin from human plasma using the Gradiflow,” Proteomics, vol. 3, no. 3, pp. 279–287, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Chandramouli and P. Y. Qian, “Proteomics: challenges, techniques and possibilities to overcome biological sample 6 complexity,” Human Genomics and Proteomics, vol. 2009, Article ID 239204, 2009. View at Publisher · View at Google Scholar
  18. M. L. Lindsey, G. P. Escobar, L. W. Dobrucki et al., “Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction,” American Journal of Physiology, vol. 290, no. 1, pp. H232–H239, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Adamsson Eryd, J. G. Smith, O. Melander, B. Hedblad, and G. Engström, “Inflammation-sensitive proteins and risk of atrial fibrillation: a population-based cohort study,” European Journal of Epidemiology, vol. 26, no. 6, pp. 449–455, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Haas, T. Serchi, D. R. Wagner et al., “Proteomic analysis of plasma samples from patients with acute myocardial infarction identifies haptoglobin as a potential prognostic biomarker,” Journal of Proteomics, vol. 75, pp. 229–236, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Di Stefano, V. Di Bello, M. C. Barsotti et al., “Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models,” Biomedicine and Pharmacotherapy, vol. 63, no. 10, pp. 773–780, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Bolignano, V. Donato, G. Coppolino et al., “Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a marker of kidney damage,” American Journal of Kidney Diseases, vol. 52, no. 3, pp. 595–605, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. S. H. Nymo, T. Ueland, E. T. Askevold, T. H. Flo, and J. Kjekshus, “The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA,” Journal of Internal Medicine, vol. 271, no. 5, pp. 436–443, 2012. View at Google Scholar
  24. A. Şahinarslan, S. A. Kocaman, D. Bas et al., “Plasma neutrophil gelatinase-associated lipocalin levels in acute myocardial infarction and stable coronary artery disease,” Coronary Artery Disease, vol. 22, no. 5, pp. 333–338, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Yndestad, L. Landrø, T. Ueland et al., “Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure,” European Heart Journal, vol. 30, no. 10, pp. 1229–1236, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. A. B. Akcay, M. F. Ozlu, N. Sen, S. Cay, and O. H. Ozturk, “Prognostic significance of neutrophil gelatinase-associated lipocalin in ST-segment elevation myocardial infarction,” Journal of Investigative Medicine, vol. 60, pp. 508–513, 2012. View at Google Scholar
  27. L. C. Cáceres, G. R. Bonacci, M. C. Sánchez, and G. A. Chiabrando, “Activated α2 macroglobulin induces matrix metalloproteinase 9 expression by low-density lipoprotein receptor-related protein 1 through MAPK-ERK1/2 and NF-κB activation in macrophage-derived cell lines,” Journal of Cellular Biochemistry, vol. 111, no. 3, pp. 607–617, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. L. F. Arbeláez, U. Bergmann, A. Tuuttila, V. P. Shanbhag, and T. Stigbrand, “Interaction of matrix metalloproteinases-2 and -9 with pregnancy zone protein and α2-macroglobulin,” Archives of Biochemistry and Biophysics, vol. 347, no. 1, pp. 62–68, 1997. View at Publisher · View at Google Scholar · View at Scopus
  29. N. A. Trueblood, Z. Xie, C. Communal et al., “Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin,” Circulation Research, vol. 88, no. 10, pp. 1080–1087, 2001. View at Google Scholar · View at Scopus